High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa

INTRODUCTION: Treatment success rates of rifampicin resistant (RR)/multi-drug resistant (MDR) tuberculosis (TB) in South Africa range from 43–48%, falling short of the World Health Organization’s target of ≥75%. We present rates and assess predictors of attrition by 12 months on treatment. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirasen, Kamban, Berhanu, Rebecca, Evans, Denise, Rosen, Sydney, Sanne, Ian, Long, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177165/
https://www.ncbi.nlm.nih.gov/pubmed/30300403
http://dx.doi.org/10.1371/journal.pone.0205463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177165/
https://www.ncbi.nlm.nih.gov/pubmed/30300403
http://dx.doi.org/10.1371/journal.pone.0205463

Ejemplares similares